Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatectomy | 8 | 2017 | 66 | 1.800 |
Why?
|
| Pancreatic Neoplasms | 5 | 2019 | 131 | 1.540 |
Why?
|
| Postoperative Complications | 7 | 2018 | 670 | 1.470 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2018 | 32 | 1.240 |
Why?
|
| Bile Duct Neoplasms | 4 | 2015 | 36 | 1.160 |
Why?
|
| Retrospective Studies | 20 | 2019 | 3111 | 0.930 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2014 | 19 | 0.920 |
Why?
|
| Pancreatectomy | 5 | 2014 | 29 | 0.880 |
Why?
|
| Pancreaticoduodenectomy | 3 | 2017 | 21 | 0.840 |
Why?
|
| Aged | 25 | 2019 | 9487 | 0.830 |
Why?
|
| Liver Neoplasms | 4 | 2017 | 162 | 0.810 |
Why?
|
| Female | 34 | 2019 | 18164 | 0.810 |
Why?
|
| Cause of Death | 2 | 2014 | 220 | 0.800 |
Why?
|
| Middle Aged | 26 | 2018 | 10829 | 0.790 |
Why?
|
| Male | 28 | 2019 | 17807 | 0.710 |
Why?
|
| Neoplasm Staging | 9 | 2016 | 436 | 0.710 |
Why?
|
| Biliary Dyskinesia | 1 | 2019 | 2 | 0.700 |
Why?
|
| Humans | 37 | 2019 | 29093 | 0.700 |
Why?
|
| Risk Assessment | 9 | 2018 | 1305 | 0.690 |
Why?
|
| Adenocarcinoma | 4 | 2019 | 301 | 0.660 |
Why?
|
| Gallbladder Neoplasms | 2 | 2015 | 33 | 0.660 |
Why?
|
| Survivors | 2 | 2016 | 145 | 0.650 |
Why?
|
| Bile Ducts, Intrahepatic | 3 | 2013 | 9 | 0.640 |
Why?
|
| Cholangiocarcinoma | 3 | 2013 | 14 | 0.640 |
Why?
|
| Survival Rate | 8 | 2017 | 795 | 0.640 |
Why?
|
| Breast Neoplasms | 4 | 2018 | 666 | 0.640 |
Why?
|
| Cohort Studies | 8 | 2016 | 1687 | 0.630 |
Why?
|
| Computer Systems | 1 | 2017 | 12 | 0.620 |
Why?
|
| Preoperative Care | 1 | 2018 | 110 | 0.610 |
Why?
|
| Vascular Surgical Procedures | 2 | 2015 | 91 | 0.610 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2017 | 20 | 0.610 |
Why?
|
| Abdomen | 1 | 2017 | 42 | 0.600 |
Why?
|
| Frail Elderly | 1 | 2017 | 65 | 0.590 |
Why?
|
| Pancreatitis, Chronic | 1 | 2016 | 8 | 0.570 |
Why?
|
| Hospital Mortality | 2 | 2016 | 186 | 0.570 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2016 | 31 | 0.560 |
Why?
|
| Exercise Therapy | 1 | 2018 | 229 | 0.550 |
Why?
|
| Patient Care | 1 | 2016 | 33 | 0.550 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2015 | 7 | 0.550 |
Why?
|
| Neoplasm Invasiveness | 5 | 2014 | 189 | 0.540 |
Why?
|
| Bile Ducts | 1 | 2015 | 18 | 0.540 |
Why?
|
| Blood Vessels | 1 | 2015 | 47 | 0.520 |
Why?
|
| SEER Program | 5 | 2016 | 32 | 0.510 |
Why?
|
| Ileal Diseases | 1 | 2014 | 3 | 0.510 |
Why?
|
| Intestinal Obstruction | 1 | 2014 | 10 | 0.510 |
Why?
|
| Hernia, Abdominal | 1 | 2014 | 10 | 0.500 |
Why?
|
| Cholelithiasis | 1 | 2014 | 10 | 0.500 |
Why?
|
| Peritoneal Neoplasms | 3 | 2014 | 241 | 0.490 |
Why?
|
| Follow-Up Studies | 11 | 2019 | 2108 | 0.480 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2013 | 7 | 0.480 |
Why?
|
| Ampulla of Vater | 1 | 2013 | 7 | 0.480 |
Why?
|
| Duodenal Neoplasms | 1 | 2013 | 6 | 0.480 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 208 | 0.470 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2013 | 13 | 0.470 |
Why?
|
| Carcinoid Tumor | 1 | 2013 | 22 | 0.470 |
Why?
|
| Hospitalization | 1 | 2016 | 417 | 0.450 |
Why?
|
| Carcinoma | 1 | 2014 | 87 | 0.450 |
Why?
|
| Depression | 1 | 2016 | 380 | 0.450 |
Why?
|
| Treatment Outcome | 11 | 2017 | 3099 | 0.450 |
Why?
|
| Pancreatitis | 1 | 2013 | 18 | 0.450 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 50 | 0.440 |
Why?
|
| Multivariate Analysis | 4 | 2016 | 637 | 0.430 |
Why?
|
| Length of Stay | 4 | 2017 | 292 | 0.430 |
Why?
|
| United States | 7 | 2018 | 3630 | 0.420 |
Why?
|
| Fundoplication | 1 | 2011 | 8 | 0.410 |
Why?
|
| Gastroparesis | 1 | 2011 | 10 | 0.410 |
Why?
|
| Gastroesophageal Reflux | 1 | 2011 | 25 | 0.410 |
Why?
|
| Gastrectomy | 1 | 2011 | 65 | 0.400 |
Why?
|
| Lymph Node Excision | 1 | 2011 | 89 | 0.400 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2011 | 21 | 0.390 |
Why?
|
| Breast Diseases | 1 | 2010 | 4 | 0.380 |
Why?
|
| Scleroderma, Localized | 1 | 2010 | 5 | 0.380 |
Why?
|
| Patient Transfer | 1 | 2011 | 34 | 0.380 |
Why?
|
| Erythema | 1 | 2010 | 27 | 0.370 |
Why?
|
| Patient Care Planning | 1 | 2011 | 53 | 0.370 |
Why?
|
| Prognosis | 7 | 2019 | 1362 | 0.360 |
Why?
|
| African Americans | 1 | 2016 | 1373 | 0.350 |
Why?
|
| Survival Analysis | 5 | 2014 | 440 | 0.350 |
Why?
|
| Time Factors | 5 | 2015 | 2001 | 0.320 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2017 | 401 | 0.320 |
Why?
|
| Aged, 80 and over | 7 | 2018 | 3717 | 0.310 |
Why?
|
| Hyperthermia, Induced | 3 | 2014 | 235 | 0.310 |
Why?
|
| Internship and Residency | 1 | 2011 | 283 | 0.300 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2014 | 337 | 0.290 |
Why?
|
| Activities of Daily Living | 2 | 2016 | 238 | 0.260 |
Why?
|
| Risk Factors | 5 | 2018 | 3531 | 0.240 |
Why?
|
| Logistic Models | 3 | 2017 | 727 | 0.230 |
Why?
|
| Adult | 10 | 2018 | 8420 | 0.230 |
Why?
|
| Minnesota | 2 | 2014 | 18 | 0.230 |
Why?
|
| Odds Ratio | 2 | 2015 | 447 | 0.220 |
Why?
|
| Vena Cava, Inferior | 2 | 2012 | 31 | 0.220 |
Why?
|
| Proportional Hazards Models | 3 | 2013 | 709 | 0.210 |
Why?
|
| Age Factors | 2 | 2016 | 1108 | 0.210 |
Why?
|
| Academic Medical Centers | 2 | 2014 | 150 | 0.210 |
Why?
|
| Recurrence | 2 | 2013 | 235 | 0.200 |
Why?
|
| Lymphatic Metastasis | 4 | 2016 | 156 | 0.190 |
Why?
|
| Mastectomy | 2 | 2018 | 59 | 0.180 |
Why?
|
| Omentum | 2 | 2017 | 26 | 0.180 |
Why?
|
| Surgical Wound Infection | 2 | 2018 | 74 | 0.180 |
Why?
|
| Feasibility Studies | 2 | 2017 | 263 | 0.170 |
Why?
|
| Neuroendocrine Tumors | 1 | 2019 | 20 | 0.170 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 3 | 2014 | 146 | 0.170 |
Why?
|
| Neoplasms | 2 | 2014 | 610 | 0.160 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 871 | 0.160 |
Why?
|
| Databases, Factual | 2 | 2018 | 332 | 0.160 |
Why?
|
| Hospital Information Systems | 1 | 2017 | 2 | 0.150 |
Why?
|
| Computer Communication Networks | 1 | 2017 | 5 | 0.150 |
Why?
|
| Tumor Burden | 2 | 2016 | 60 | 0.150 |
Why?
|
| Hematologic Diseases | 1 | 2017 | 23 | 0.150 |
Why?
|
| Digestive System Neoplasms | 1 | 2017 | 4 | 0.150 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2017 | 19 | 0.150 |
Why?
|
| Incidence | 2 | 2017 | 1119 | 0.150 |
Why?
|
| Laparotomy | 1 | 2017 | 32 | 0.150 |
Why?
|
| Morbidity | 1 | 2017 | 91 | 0.150 |
Why?
|
| Cells, Immobilized | 1 | 2017 | 23 | 0.150 |
Why?
|
| Mastectomy, Segmental | 1 | 2016 | 23 | 0.150 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2017 | 40 | 0.140 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2017 | 51 | 0.140 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2017 | 43 | 0.140 |
Why?
|
| Analgesia, Epidural | 1 | 2017 | 50 | 0.140 |
Why?
|
| Islets of Langerhans | 1 | 2017 | 74 | 0.140 |
Why?
|
| Health Surveys | 1 | 2016 | 191 | 0.140 |
Why?
|
| Walking | 1 | 2017 | 177 | 0.140 |
Why?
|
| Mammaplasty | 2 | 2018 | 27 | 0.140 |
Why?
|
| Safety | 1 | 2016 | 72 | 0.140 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 49 | 0.130 |
Why?
|
| Shock, Septic | 1 | 2015 | 28 | 0.130 |
Why?
|
| Lung Diseases | 1 | 2015 | 45 | 0.130 |
Why?
|
| Health Care Surveys | 1 | 2016 | 176 | 0.130 |
Why?
|
| Geriatric Assessment | 1 | 2017 | 355 | 0.130 |
Why?
|
| Health Status | 1 | 2017 | 368 | 0.130 |
Why?
|
| Young Adult | 3 | 2017 | 2402 | 0.130 |
Why?
|
| Medicare | 1 | 2016 | 186 | 0.130 |
Why?
|
| Pain, Postoperative | 1 | 2017 | 174 | 0.130 |
Why?
|
| Abdominal Cavity | 1 | 2014 | 6 | 0.130 |
Why?
|
| Abdominal Neoplasms | 1 | 2014 | 15 | 0.120 |
Why?
|
| Pancreas | 1 | 2015 | 79 | 0.120 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 129 | 0.120 |
Why?
|
| Reference Values | 1 | 2014 | 224 | 0.120 |
Why?
|
| Disease-Free Survival | 2 | 2013 | 281 | 0.120 |
Why?
|
| Laparoscopy | 2 | 2017 | 169 | 0.110 |
Why?
|
| Portal Vein | 1 | 2012 | 16 | 0.110 |
Why?
|
| Giant Cells | 1 | 2012 | 4 | 0.110 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2012 | 5 | 0.110 |
Why?
|
| Sarcoma, Synovial | 1 | 2012 | 6 | 0.110 |
Why?
|
| Vascular Neoplasms | 1 | 2012 | 14 | 0.110 |
Why?
|
| Pancreatic Fistula | 1 | 2012 | 3 | 0.110 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2012 | 57 | 0.110 |
Why?
|
| Pericardium | 1 | 2012 | 50 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2012 | 60 | 0.100 |
Why?
|
| Sex Factors | 1 | 2014 | 631 | 0.100 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 787 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2014 | 859 | 0.100 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 199 | 0.100 |
Why?
|
| Quality of Life | 1 | 2016 | 816 | 0.100 |
Why?
|
| Mammography | 1 | 2011 | 37 | 0.100 |
Why?
|
| Treatment Failure | 1 | 2011 | 159 | 0.100 |
Why?
|
| Efficiency, Organizational | 1 | 2011 | 18 | 0.100 |
Why?
|
| Total Quality Management | 1 | 2011 | 19 | 0.100 |
Why?
|
| Hospitals, Teaching | 1 | 2011 | 28 | 0.100 |
Why?
|
| Interprofessional Relations | 1 | 2011 | 47 | 0.100 |
Why?
|
| Medical Errors | 1 | 2011 | 36 | 0.100 |
Why?
|
| Peritoneal Lavage | 1 | 2010 | 2 | 0.090 |
Why?
|
| Obesity | 1 | 2018 | 1063 | 0.090 |
Why?
|
| Linear Models | 1 | 2011 | 426 | 0.090 |
Why?
|
| Cytodiagnosis | 1 | 2010 | 16 | 0.090 |
Why?
|
| Reoperation | 1 | 2011 | 203 | 0.090 |
Why?
|
| Stents | 1 | 2012 | 171 | 0.090 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2012 | 190 | 0.090 |
Why?
|
| Program Evaluation | 1 | 2011 | 175 | 0.090 |
Why?
|
| Probability | 1 | 2010 | 150 | 0.090 |
Why?
|
| General Surgery | 1 | 2011 | 81 | 0.090 |
Why?
|
| Biopsy, Needle | 1 | 2010 | 89 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2011 | 124 | 0.090 |
Why?
|
| Patient Selection | 1 | 2011 | 257 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 1218 | 0.090 |
Why?
|
| Combined Modality Therapy | 3 | 2014 | 525 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 493 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 519 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 863 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2017 | 2019 | 0.070 |
Why?
|
| Adolescent | 3 | 2018 | 3254 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2014 | 163 | 0.060 |
Why?
|
| Hypoalbuminemia | 1 | 2017 | 9 | 0.040 |
Why?
|
| Lymphopenia | 1 | 2017 | 11 | 0.040 |
Why?
|
| Leucovorin | 1 | 2017 | 20 | 0.040 |
Why?
|
| Hypokalemia | 1 | 2017 | 14 | 0.040 |
Why?
|
| Neutropenia | 1 | 2017 | 23 | 0.040 |
Why?
|
| Sensation Disorders | 1 | 2017 | 19 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2017 | 32 | 0.040 |
Why?
|
| Maximum Tolerated Dose | 1 | 2017 | 56 | 0.040 |
Why?
|
| Sulfides | 1 | 2017 | 24 | 0.040 |
Why?
|
| Caprylates | 1 | 2017 | 25 | 0.040 |
Why?
|
| Organoplatinum Compounds | 1 | 2017 | 42 | 0.040 |
Why?
|
| Camptothecin | 1 | 2017 | 48 | 0.040 |
Why?
|
| Abdominal Pain | 1 | 2017 | 40 | 0.040 |
Why?
|
| Capsules | 1 | 2017 | 14 | 0.040 |
Why?
|
| Anemia | 1 | 2017 | 55 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2017 | 73 | 0.040 |
Why?
|
| Fluid Therapy | 1 | 2017 | 27 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2017 | 36 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2017 | 82 | 0.040 |
Why?
|
| Blood Transfusion | 1 | 2017 | 64 | 0.040 |
Why?
|
| Alginates | 1 | 2017 | 49 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 1 | 2017 | 62 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 231 | 0.040 |
Why?
|
| Cell Survival | 1 | 2017 | 272 | 0.030 |
Why?
|
| Forecasting | 1 | 2016 | 133 | 0.030 |
Why?
|
| Sepsis | 1 | 2017 | 146 | 0.030 |
Why?
|
| Graft Survival | 1 | 2017 | 228 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2017 | 364 | 0.030 |
Why?
|
| Hepatic Artery | 1 | 2015 | 10 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 540 | 0.030 |
Why?
|
| Insulin | 1 | 2017 | 346 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2018 | 865 | 0.030 |
Why?
|
| Colectomy | 1 | 2014 | 25 | 0.030 |
Why?
|
| Mitomycin | 1 | 2014 | 45 | 0.030 |
Why?
|
| Cisplatin | 1 | 2014 | 69 | 0.030 |
Why?
|
| Diaphragm | 1 | 2014 | 46 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2014 | 147 | 0.030 |
Why?
|
| Hepatic Veins | 1 | 2012 | 4 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2012 | 4 | 0.030 |
Why?
|
| Rats | 1 | 2017 | 1604 | 0.030 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2012 | 68 | 0.030 |
Why?
|
| Ablation Techniques | 1 | 2012 | 24 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2012 | 40 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2012 | 64 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2013 | 454 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2012 | 75 | 0.030 |
Why?
|
| Heart Atria | 1 | 2012 | 62 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 2012 | 79 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2011 | 91 | 0.020 |
Why?
|
| Mice | 1 | 2017 | 2368 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 532 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 546 | 0.020 |
Why?
|
| Animals | 1 | 2017 | 7297 | 0.020 |
Why?
|